Multi-energy CT (also known as spectral CT) exploits the attenuation variations observed when composite materials are imaged by X-rays of differing energies. The article's authors, from Philips Research in Germany and Philips Healthcare in Israel, demonstrated spectral CT imaging of a phantom containing PMMA, calcium-hydroxyapatite, water, and varying concentrations of gadolinium- and iodine-based contrast agents.

The researchers - headed up by Philips' Jens-Peter Schlomka - generated separate images showing the attenuation due to photoelectric absorption, Compton scattering, iodine and gadolinium. Calculated concentrations of the contrast agents based on their observed attenuation matched well with the actual doses used. This quantitative imaging is a major differentiator of spectral CT over conventional or dual-energy CT (see also: Spectral CT picks out multiple materials).

"This work represented a major step forward in taking spectral CT from a theoretical concept to an imaging tool to help improve diagnosis and therapy planning for many of the world's major diseases," Schlomka told medicalphysicsweb. "We have learnt from the feedback that we have received so far that this paper has helped convince many people of the feasibility of spectral CT imaging."

Since the PMB paper was published last year, the researchers have enhanced the spectral CT system's scanning hardware and image reconstruction software to offer better image quality and easier object handling. They are now working to speed up the system - a key challenge in developing a clinical spectral CT scanner.

The enhanced spectral CT prototype has been employed to study phantom models and tissue samples, in the search for novel spectral CT contrast agents. "We initially targeted the structural and functional imaging capabilities of spectral CT for cardiovascular diseases, but the principles can be transferred to other clinical application areas such as oncology," explained Schlomka.

"I recently switched position from being an 'active' researcher to managing other researchers, heading the X-ray imaging group within Philips Research in Aachen, Germany," Schlomka added. "Receiving this prize makes me proud, of course; it is a great achievement for me on the finishing line of my career as an active researcher."

Top choices
The Roberts Prize is a joint award from IOP Publishing, the publishers of PMB, and the journal owners, the Institute of Physics and Engineering in Medicine (IPEM). Starting with a shortlist of the best 10 research papers published in 2008 (based on the referees' quality assessments), an IPEM college of jurors choose a winner, which was then endorsed by the Editorial Board.

This year, it was a close contest between the top two papers, with the Board particularly commending the runner-up (Phys. Med. Biol. 53 6291). The second-place paper, by Chao Wang et al, describes arc-modulated radiation therapy (AMRT), an alternative method of delivering intensity-modulated radiotherapy. The article describes an AMRT treatment planning scheme, and details the verification of this scheme with multiple clinical cases (see also: Single-arc IMRT: variations on a theme).

The following ten articles (listed in alphabetical order) were shortlisted for the 2008 Roberts Prize:

More information on the shortlisted papers can be found here.